Cao Guo

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Erratum: Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Erratum: Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Journal: iScience

Published: March 19, 2026

Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma.

Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma.

Journal: Journal of hepatocellular carcinoma

Published: February 12, 2026

Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Journal: iScience

Published: February 14, 2024

PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous.

PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: October 30, 2023

DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3.

DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3.

Journal: Cancer cell international

Published: July 25, 2023

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.

A multi-omics analysis reveals CLSPN is associated with prognosis, immune microenvironment and drug resistance in cancers.

Journal: Biological procedures online

Published: February 28, 2023

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.

The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.

Journal: Frontiers in pharmacology

Published: August 09, 2022

The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation.

The long noncoding RNA TINCR promotes self-renewal of human liver cancer stem cells through autophagy activation.

Journal: Cell death & disease

Published: July 06, 2022

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: May 24, 2022

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

Journal: iScience

Published: February 25, 2022

Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism.

Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolism.

Journal: International journal of biological sciences

Published: January 16, 2022

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Journal: EBioMedicine

Published: September 28, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026